chr9-128605117-T-C
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_ModerateBP6_Very_StrongBS2
The NM_001130438.3(SPTAN1):c.3803T>C(p.Val1268Ala) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000868 in 1,613,720 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. V1268V) has been classified as Likely benign.
Frequency
Consequence
NM_001130438.3 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 5Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine
- genetic developmental and epileptic encephalopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- infantile spasmsInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -14 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_001130438.3. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTAN1 | NM_001130438.3 | MANE Select | c.3803T>C | p.Val1268Ala | missense | Exon 30 of 57 | NP_001123910.1 | ||
| SPTAN1 | NM_001375318.1 | c.3839T>C | p.Val1280Ala | missense | Exon 31 of 59 | NP_001362247.1 | |||
| SPTAN1 | NM_001375310.1 | c.3803T>C | p.Val1268Ala | missense | Exon 30 of 58 | NP_001362239.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SPTAN1 | ENST00000372739.7 | TSL:1 MANE Select | c.3803T>C | p.Val1268Ala | missense | Exon 30 of 57 | ENSP00000361824.4 | ||
| SPTAN1 | ENST00000372731.8 | TSL:1 | c.3803T>C | p.Val1268Ala | missense | Exon 30 of 56 | ENSP00000361816.4 | ||
| SPTAN1 | ENST00000358161.9 | TSL:1 | c.3743T>C | p.Val1248Ala | missense | Exon 29 of 55 | ENSP00000350882.6 |
Frequencies
GnomAD3 genomes AF: 0.0000856 AC: 13AN: 151828Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.000131 AC: 33AN: 251428 AF XY: 0.000132 show subpopulations
GnomAD4 exome AF: 0.0000869 AC: 127AN: 1461892Hom.: 0 Cov.: 31 AF XY: 0.0000921 AC XY: 67AN XY: 727248 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000856 AC: 13AN: 151828Hom.: 0 Cov.: 32 AF XY: 0.0000944 AC XY: 7AN XY: 74156 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Developmental and epileptic encephalopathy Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at